Impact of Sao2/Fio2 Delta Value on Mortality in Critically III Patients with ARDS and COVID-19 in Prone Position

Article Sidebar

PDF
Published: Aug 11, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i8-28
Keywords:
SaO2/FiO2 delta value ARDS COVID-19 PRONE POSITION CRITICALLY ILL PATIENT

Main Article Content

Carlos Jiménez-Correa
INSTITUTO MEXICANO DEL SEGURO SOCIALCritical Care Medicine and Emergency Medicine Physician. Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 1, Centro Médico Nacional del Bajío (IMSS, UMAE HE No. 1 CMN), León, Guanajuato, Mexico. Intensive Care Unit
Carlos Eduardo Rodríguez-Cázares
Critical Care Medicine and Emergency Medicine Physician. Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 1, Centro Médico Nacional del Bajío (IMSS, UMAE HE No. 1 CMN), León, Guanajuato, Mexico. Intensive Care Unit
Ma. Natalia Gómez-González
Master's degree in clinical research, Critical Care Medicine and Anesthesiologist Physician. IMSS, UMAE HE No. 1 CMN, León, Guanajuato. Mexico. Intensive Care Unit.
Deisy De Jesús- Balcázar
Critical Care Medicine and Emergency Medicine Physician. Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 1, Centro Médico Nacional del Bajío (IMSS, UMAE HE No. 1 CMN), León, Guanajuato, Mexico. Intensive Care Unit
Pedro Luis González-Carrillo
Critical Care Medicine and Emergency Medicine Physician. Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 1, Centro Médico Nacional del Bajío (IMSS, UMAE HE No. 1 CMN), León, Guanajuato, Mexico. Intensive Care Unit

Abstract

Introduction: The COVID 19 pandemic generated in December 2019 has come to change paradigms in terms of ventilatory support measures worldwide, continuous clinical monitoring allows timely decision making impacting mortality in patients with ARDS.


Objective: To identify the relationship between the SO2/FiO2 delta and mortality in critically ill patients with ARDS and COVID-19 in prone position.


Material and methods: Retrospective, observational, comparative, analytical study, where all patients who met the inclusion criteria were evaluated: under mechanical ventilation and prone position for acute respiratory failure secondary to SARS-CoV-2 infection, measuring the value of SO2/FiO2 before and after the change of position to prone position, also mortality was recorded. 


Results: A total of 74 patients were analyzed, 33 corresponding to the survivors and 41 to the non-survivors group. The median age was 53.5 ± 12.77, with a male predominance. The mean days of mechanical ventilation were 10.64 ±5.16.  A ROC curve was also performed for D SaO2/FiO2 and survival (AUC 0.668, p=0.013) for predicting patient survival.


Conclusion: Continuous clinical monitoring is necessary to optimize resources in the different hospital and out-of-hospital areas. D SO2/FiO2 can be very useful for the continuous monitoring and prognosis in COVID-19 critical patients.

Article Details

How to Cite
Jiménez-Correa, C., Rodríguez-Cázares , C. E. ., Gómez-González , M. N. ., Jesús- Balcázar , D. D., & González-Carrillo, P. L. (2023). Impact of Sao2/Fio2 Delta Value on Mortality in Critically III Patients with ARDS and COVID-19 in Prone Position . International Journal of Medical Science and Clinical Research Studies, 3(8), 1595–1599. https://doi.org/10.47191/ijmscrs/v3-i8-28
Issue
Vol. 3 No. 8 (2023): Volume 03 Issue 08 August 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. World Health Organization Weekly epidemiological update - 9 March 2021.

II. Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). 2020.

III. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-1062.

IV. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069.

V. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.

VI. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID- 19 in the New York City area. JAMA 2020;323:2052-2059.

VII. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1089-1098.

VIII. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-690.

IX. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-818.

X. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.

XI. Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res. 2015;7(1):28-31.

XII. Li X, Ma X. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care. 2020 May 6;24(1):198.

XIII. Tobin M. J. Does Making a Diagnosis of ARDS in Patients With Coronavirus Disease 2019 Matter? Chest 2020; 158:6, 2275–2277.

XIV. Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020;202(3):356-360.

XV. Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thoracic Rev. 2015;7(1):28-31.

XVI. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-1242.

XVII. Hafen BB, Sharma S. Oxygen Saturation. In: StatPearls. Treasure Island (FL): StatPearls 2021.

XVIII. Tobin MJ. Why Physiology Is Critical to the Practice of Medicine: A 40-year Personal Perspective. Clin Chest Med. 2019 Jun; 40(2):243-257.

XIX. Tobin MJ. Basing Respiratory Management of COVID-19 on Physiological Principles. Am J Respir Crit Care Med. 2020;201(11):1319-1320.

XX. Festic, E., Bansal, V., Kor, D. J., & Gajic, O. SpO2/FiO2 Ratio on Hospital Admission Is an Indicator of Early Acute Respiratory Distress Syndrome Development Among Patients at Risk. Journal of Intensive Care Medicine, 2015;30(4), 209–216.

XXI. Rice, TW, Wheeler, AP, Bernard, GR. Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132(2):410–417.

XXII. Bashar, F.R., Vahedian-Azimi, A., Farzanegan, B, et al. Comparison of non- invasive to invasive oxygenation ratios for diagnosing acute respiratory distress syndrome following coronary artery bypass graft surgery: a prospective derivation-validation cohort study. J Cardiothorac Surg 13, 2018;123.

XXIII. DesPrez K, McNeil JB, Wang C, et al. Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS. Chest. 2017 Dec;152(6):1151-1158.

XXIV. Catoire P, Tellier E, de la Rivière C, et al. Assessment of the SpO2/FiO2 ratio as a tool for hypoxemia screening in the emergency department [published online ahead of print, 2021 Feb 6]. Am J Emerg Med. 2021;44:116-120.

XXV. Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 6;368(23):2159-68.

XXVI. Weiss TT, Cerda F, Scott JB, et al. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study.Br J Anaesth. 2021;126(1):48-55.

XXVII. Xiaofan Lu, Liyun Jiang, Taige Chen, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respiratory Research. 194 (2020).